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Abstract: In this research Ce3+ doped Captopril 
nanoparticles (Ce3+ doped CAP-NP) were prepared by a 
cold welding process and have been studied. Captopril 
may be applied in the treatment of hypertension and 
some types of congestive heart failure and for preventing 
kidney failure due to high blood pressure and diabetes. 
CAP-NP was synthesized by a cold welding process. The 
cerium nitrate was added at a ratio of 10% and the optical 
properties have been studied by photoluminescence 
(PL). The synthesized compounds were characterized 
by Fourier transform infrared spectroscopy. The size of 
CAP-NP was calculated by X- ray diffraction (XRD). The 
size of CAP-NP was in the range of 50 nm. Morphology 
of surface of synthesized nanoparticles was studied 
by scanning electron microscopy (SEM). Finally the 
luminescence properties of undoped and doped CAP-NP 
were compared. PL spectra from undoped CAP-NP show 
a strong pack in the range of 546 nm after doped cerium 
ion into the captopril appeared two bands at 680 and 
357 nm, which is ascribed to the well-known 5d–4f 
emission band of the cerium. 
Keywords: Doped, Ce3+, Photoluminescence, Caporal, 
SEM, XRD
1 Introduction
Particles that have size between 1 and 100 nanometers 
are called nanoparticles [1]. Nanoparticles have a large 
surface per volume ratio. These properties lead to the use 
of nanoparticles in many applications such as medicine, 
electronics, etc. [2].
Captopril is an orally active drug and a member of 
a class of drugs called angiotensin converting enzyme 
(ACE) inhibitors. ACE inhibitors are another family 
of antihypertensive drugs that decrease the levels 
of angiotensin II in the human body. This enzyme is 
responsible for the conversion of angiotensin I (ATI) to 
angiotensin II (ATII). AT II regulates blood pressure and 
is a key component of the renin-angiotensin-aldosterone 
system (RAAS) [3,4,5]. Captopril is also the only drug 
that includes sulfhydryl group. Its chemical formula is 
following: 1-[(2S)-3-mercapto-2-methylpropionyl]-L proline 
[6,7].
Renin is an enzyme that is synthesized by the kidneys 
and is released into the blood stream wherever it stirs on a 
plasma globulin to supply angiotensin. Then by ACE it is 
converted to angiotensin II. Captopril, by inhibiting  ACE, 
prevents the conversion of angiotensin I to angiotensin II. 
Therefore ACE inhibition results in reduced angiotensin II 
and enhanced plasma renin activity (PRA) [8-10]. Captopril 
is used in the management of high blood pressure 
(hypertension), congestive heart failure, kidney problems 
caused by diabetes and it improves survival after a heart 
attack [11].
Cerium nitrate is the cheapest and most abundant 
source of cerium. Cerium nitrate is an effective 
antibacterial substance against a range of bacteria, such 
as Staphylococcus aureus and Escherichia coli [12-14]. 
In this research, Ce3+ doped CAP-NP were synthesized by 
a cold welding process and its features were investigated. 
The CAP-NPs were analysed by FT- IR spectroscopy and 
X-ray diffraction (XRD) was undertaken to determine the 
CAP-NP size, using the Debye-Scherrer formula. CAP-NP 
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size was calculated from the full width at half maximum 
(FWHM) which was found to be approximately 34 nm. 
The morphology of CAP-NP and Ce3+ doped CAP-NP were 
investigated by scanning electronic microscopy (SEM). 
The PL spectra from Ce3+ doped CAP-NP shows two broad 
bands at 680 and 357 nm, which are assigned to the Ce3+ 
ion transiting from the 5d level to the 4f ground states, 
then compared with undoped CAP-NP and Ce(NO3)3. 
2 Experimental
2.1 Materials and instruments
Captopril was received as gift samples from the Iran 
Drug Company. Captopril drug was produced as an 
active substance and without impurities. Ce (NO3)3 with 
a purity of 98.5% was purchased from Merck. CAP-NP 
was prepared by ball milling (satellite “Pulverisette 
7 classic line” (Fritsch GmbH, Germany). The surface 
of the product was characterized by scanning electron 
microscopy (SEM) model AIS2100 from Soren technology 
and prior to analysis the sample was covered by thin 
layers of gold. A Philips X-pert x-ray diffractometer with 
Cu Kα (λ = 1.54 Å) radiation was used to study the CAP-
NPs at room temperature. Emission spectra of Ce3+ doped 
CAP-NP  and CAP-NP were collected using a fluorescent 
spectrophotometer (Cary Eclipse 4000) at excitation 
wavelength of 274 nm. 
2.2 Synthesis of Ce3+ doped CAP-NP
To prepare the nanoparticles, 5 g of captopril drug were 
ball-milled at 180 RPM in an iron jar for 15 hours at an 
optimum weight ratio of ball to powder. The CAP-NP 
was kept in the dark glass to avoid any decomposition 
reactions. Then 10% Ce(NO3)3 was added to the CAP-
NP and they were ball-milled at 180 RPM for a further 
5 hours.
2.3 Characterization of CAP-NP and Ce3+ 
doped CAP-NP
X-ray diffraction (XRD) was used to determine the CAP-NP 
size by using  the FWHM obtained from the largest peak 
(Fig. 1). (Due to the low amount of cerium as the doping 
agent, XRD spectra showed no change after doping 
cerium to captopril so presence of cerium examined 
with photoluminescence spectra). FTIR has been used 
to investigate possible interactions of functional groups 
between CAP-NP and Ce3+ doped CAP-NP in the range 
400 to 4000 cm-1 (Fig. 2). Morphology of CAP-NP and Ce3+ 
doped CAP-NP were investigated using scanning electron 
microscopy (SEM) – Figs. 3a and 3b. PL spectra of Ce3+ 
doped CAP-NP and CAP-NP shows bands at 680 and 357 nm 
compared to Ce(NO3)3 PL spectra, as shown in Fig. 4.
3 Results and Discussion
3.1 Powder X-ray diffraction (XRD) 
Fig. 1 shows the XRD pattern of CAP-NP prepared by 
the planetary high-energy ball mill process. According 
to the results of X-ray diffraction the size of the CAP-NP 
nanoparticles was calculated from the full width at half 
maximum (FWHM) technique using Scherer’s formula. 
D = K λ/(β cos θ) where K is the constant (0.99), λ is the 
wavelength of Cu-Kα (1.54 Å) line, β is the FWHM and θ is 
the diffraction angle. Size of CAP-NP obtained in the range 
of 34 nm.
d = K λ/(β cos θ)
FWHM = 0.2548  β = 0.00444              cos θ = 0.97    
2θ = 19.6770  D = 34.68 nm
X-ray diffraction peaks are much broader when particle 
size is smaller than 100 nm. CAP-NP has a crystalline 
structure, and exhibits additional sharper peaks around 
2θ = 19.67°.
Figure 1: X-ray diffraction pattern of CAP-NP.
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3.2 Analysis of Fourier transform infrared 
spectroscope (FTIR)  
We reported the synthesis of Ce3+ doped CAP-NP and it 
was confirmed by FT-IR (Fig. 2b). The Ce3+ doped CAP-NP 
were studied and compared to CAP-NP in the range of 
400 to 4000 cm-1, Fig. 2a. In the CAP-NP, the peaks at 2979 
and 2877 cm-1 were assigned to the asymmetric CH3 and 
CH2 stretching vibration, and the peak at 2634 cm-1 was 
due to the symmetric CH3 stretching mode. The peak at 
2567 cm-1 corresponded to the SH stretching vibration [15]. 
The peaks at 1747 and 1593 cm-1 were assigned to the C=O 
stretching vibration of carboxylic acid and amide band, 
respectively. The peaks at 1471 and 1385 cm-1 were due to 
the asymmetric and symmetric CH3 bending vibrations, 
respectively. The peak at 1330 cm-1 was assigned to the 
OH bending vibration. The peaks at 1228–1200 cm-1 also 
corresponded to the C-O and/or CN stretching vibrations 
[16,17]. The peak at 3424−3474 cm-1 assigned to the O-H 
stretching vibration. This peak was broad because of 
the presence OH bond of Ce(NO3) × 6H2O in Fig. 2b and 
compared with CAP-NP in Fig. 2a that indicated that there 
were some changes in the structure due to the presence of 
cerium.
Figure 2: FT- IR spectrum of a) CAP-NP and b) Ce3+ doped CAP-NP.
Figure 3: (a) SEM pictures of CAP-NP with magnification 7.0 kv (b) Ce3+ doped CAP-NP with magnification 20.0 kv.
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3.3 Scanning electron microscopy (SEM)
SEM was used to investigate solid state of physical structure 
of the prepared CAP-NP. Fig. 3a is a SEM image of the CAP-
NP that confirmed the surface morphology is similar to 
the spherical particles with a uniform distribution. Due to 
the high surface energy of the fine particles being created, 
particles have stuck together and formed agglomerates. 
The spherical morphology obtained by cold welding 
process is similar to the morphology obtained by the co-
precipitation method [18]. Fig. 3b is a SEM image of the 
Ce3+ doped CAP-NP that confirmed the surface morphology 
is similar to the spherical particles with some of particles 
showing an irregular edged shape. There is a considerable 
agglomeration of particles. Presence of cubic structure 
among the accumulated spherical particles of CAP-NP has 
been identified.
3.4 Photoluminescence (PL) Results 
Cerium is a three valent mineral material and has a 4f 1 5d0 
ground state and a 4f 0 5d 1 first excited state. The ground 
state of Ce 3+ split in two sub bands of 2F5/2 and 2F7/2. 
Emission from Ce3+ is according to dipole transition of 
4f-5d, which has a permitted parity and spin with a fairly 
strong vibration force [19-21].
 PL spectra from Ce3+ doped CAP-NP were recorded 
at room temperature with 274 nm excitation, shown in 
Fig. 4a. There are two UV and visible emissions at 
357 and 680 nm, which is ascribed to the well-known 
5d–4f emission band of the cerium ion. The intense peak at 
680 nm can be assigned to the 5D0–7F0 transition. The PL 
broad band at 357 nm is due to the cerium ion transitions 
2D3/2–2F5/2 and 2D3/2–2F7/2 [22]. Also a strong peak in 547 nm 
that is characterized by CAP-NP. However, these features 
were not able to be detected from undopped captopril 
(Fig. 4b). Comparison of the spectra shows that these 
features are related to the Ce 3+ luminescence centers 
present in the doped material. Due to the presence of 
cerium in captopril crystalline structure the cerium 
emission intensity increased. The PL spectra of Ce3+ doped 
CAP-NP and CAP-NP and Ce(NO3)3 are compared in Fig. 4.
4 Conclusions
In summary, the synthesis and characterization of 
Ce3+ doped CAP-NP has been described. The molecular 
structure of the nanoparticles and their functional group 
was confirmed by FT-IR spectra. SEM images of the 
Ce3+ doped CAP-NP and CAP-NP confirmed the surface 
morphology was similar to the spherical particles with 
agglomerates. Also the size of nanoparticles was indicated 
by X-ray diffraction method for CAP-NP. According to 
photoluminescence properties of transition metals, the 
presence of a small amount of cerium in CAP-NP have 
luminescence that shows sharp broad band’s at 357 
and 680 nm, which is ascribed to the well-known 5d–4f 
emission band of the cerium ion. It is expected that this 
photoluminescence can be used in the tracking the drugs 
in the body or potentially used to follow release of the 
drug in the body and the mechanism of its effect on the 
body [23]. 
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